Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Mr. Gregory K. ChowCFO | 2,50k | 0,00 | Derivative Exercise and Retained Stock | - | 4,73k | 112,36% |
| 2026-03-04 | Mr. David PaulingChief Administrative Officer & General Counsel | 398,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,75k | 4,26% |
| 2026-03-04 | Mr. David PaulingChief Administrative Officer & General Counsel | -277,00 | 5,90k | Derivative Exercise and Sale | 21,31 | 9,75k | - |
| 2026-03-04 | Ms. Jane ChungCEO & Director | 506,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,29k | 2,44% |
| 2026-03-04 | Ms. Jane ChungCEO & Director | -282,00 | 6,01k | Derivative Exercise and Sale | 21,31 | 21,29k | - |
| 2026-03-01 | Mr. David PaulingChief Administrative Officer & General Counsel | 2,18k | 0,00 | Derivative Exercise and Retained Stock | - | 9,35k | 30,35% |
| 2026-03-01 | Mr. David PaulingChief Administrative Officer & General Counsel | -1,52k | 31,21k | Derivative Exercise and Sale | 20,47 - 20,55 | 9,35k | - |
| 2026-03-01 | Dr. Hans-Peter GerberChief Scientific Officer | 2,34k | 0,00 | Derivative Exercise and Retained Stock | - | 9,52k | 32,51% |
| 2026-03-01 | Dr. Hans-Peter GerberChief Scientific Officer | -1,63k | 33,52k | Derivative Exercise and Sale | 20,47 - 20,55 | 9,52k | - |
| 2026-03-01 | Ms. Jane ChungCEO & Director | 6,89k | 0,00 | Derivative Exercise and Retained Stock | - | 20,78k | 49,59% |
| 2026-03-01 | Ms. Jane ChungCEO & Director | -4,05k | 83,13k | Derivative Exercise and Sale | 20,47 - 20,55 | 20,78k | - |
| 2025-12-12 | Ms. Jane ChungCEO & Director | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 13,89k | 13,07% |
| 2025-12-12 | Ms. Jane ChungCEO & Director | -894,00 | 7,17k | Derivative Exercise and Sale | 8,02 | 13,89k | - |
| 2025-10-15 | Dr. Hans-Peter GerberChief Scientific Officer | 1,70k | 13,61k | Kauf | 8,00 | 7,18k | 31,00% |
| 2025-10-15 | Mr. Gregory K. ChowCFO | 1,98k | 16,00k | Kauf | 8,10 | 1,98k | - |
| 2025-10-15 | Ms. Jane ChungCEO & Director | 1,25k | 10,01k | Kauf | 8,01 | 12,29k | 11,33% |
| 2025-10-15 | Ms. Connie L. MatsuiIndependent Chair of the Board | 5,00k | 39,95k | Kauf | 7,99 | 5,00k | - |
| 2025-10-15 | Mr. David PaulingChief Administrative Officer & General Counsel | 1,25k | 9,99k | Kauf | 7,99 | 7,17k | 21,11% |
| 2025-09-18 | Dr. Hans-Peter GerberChief Scientific Officer | 2,41k | 0,00 | Derivative Exercise and Retained Stock | - | 5,48k | 78,33% |
| 2025-09-18 | Dr. Hans-Peter GerberChief Scientific Officer | -1,34k | 12,08k | Derivative Exercise and Sale | 9,00 | 5,48k | - |
| 2025-08-09 | Ms. Jane ChungCEO & Director | 1,20k | 0,00 | Derivative Exercise and Retained Stock | - | 11,04k | 12,25% |
| 2025-08-09 | Ms. Jane ChungCEO & Director | -670,80 | 5,37k | Derivative Exercise and Sale | 8,00 | 11,04k | - |
| 2025-07-08 | Dr. Barbara LeymanInsider | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 1,61k | - |
| 2025-07-08 | Dr. Barbara LeymanInsider | -894,40 | 6,98k | Derivative Exercise and Sale | 7,80 | 1,61k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
